CSDD-2017 Featured Speakers
Title: New paradigms in GPCR drug discovery
Philip S. Low, Purdue University, USA
Title: Targeted imaging and therapeutic agents for cancer, autoimmune and inflammatory diseases
Charles McKenna, University of Southern California, USA
Title: Antiviral nucleoside phosphonate prodrugs: Potency amplifiers”
Stephen Matlin, Imperial College London, UK
Title: Chemistry and health: Now is the time for a comprehensive approach
Somlyai Gabor, HYD Pharma Inc., Hungary
Title: Hydrogen/deuterium ratio is a key regulator of cell proliferation and metabolism – Drug development on submolecular basis
Xiang-Qun (Sean) Xie, NIH/NIDA USA
Title: Novel computational chemogenomics knowledge bases target hunter for system pharmacology drug discovery and translational research
Sadhana Jackson, NCI/NIH, USA
Title: CNS drug discovery and therapy
Title: Non-inhibitory pharmacological chaperones of glucocerebrosidase for the treatment of Gaucher’s and Parkinson’s disorders
Mahin Khatami, NIH, USA
Title: Safety of Current Cancer Drugs and Vaccines and Future Perspectives for a Healthier Society
Sid Topiol, 3D-2Drug LLC, USA
Title: TBA
Xiaodong Wang, University of North Carolina, USA
Title: Novel small molecule MerTK inhibitors
Gerhard Mueller, Mercachem The Netherlands
Title: Privileged structures: a versatile concept to explore new chemical space with medicinal chemistry utility
Daman Kumari, NIDDK/NIH, USA
Title: Restoring FMRP expression: an alternative treatment strategy for fragile X syndrome
Giora Z. Feuerstein, Temple Univerity, USA
Title: The essential role of pharmacology in discovery translational research
Jose Luis Perez-Gracia, Clinica Universidad de Navarra, Spain
Title: Strategies to design clinical studies to identify predictive bio-markers in cancer research: the DESIGN guidelines
Harold C. Smith, University of Rochester, USA
Title: Innate defense against HIV through APOBEC DNA mutagenic enzymes
Brent E. Korba, Georgetown University, USA
Title: Antivirals for norovirus
Nikolai Zhelev, Abertay University, UK
Title: Recent advances and novel approaches in the discovery and development of kinase inhibitors as new therapeutics in oncology and cardiology
Alan D. Rogol, University of Virginia Medical School, USA
Title: Wonders of Cigarette Smoke: Hurting Heart and Serving Cancer
Steven LaPlante, NMX Research and Solutions Inc., Canada
Title: Discovering Quality Drug Seeds by Practical NMR-based Fragment Screening
Ram Samudrala, State University of New York, USA
Title: Interactomics: Computational Analysis of Novel Drug Opportunities
Wasana Sumanasekera, Sullivan University College of Pharmacy, USA
Title: Developing New Nanomedicine Technologies for the Treatment of Chronic Pain
Apurba K Bhattacharjee, Georgetown University, USA
Title: Discovery of novel reactivators for DFP-inhibited acetylcholinesterase using in silico pharmacophore modeling
Robert Laprairie, The Scripps Research Institute, USA
Title: TBA
Mukhtar Dauda, Bayero University, Nigeria
Title: Surveillance for hepatitis B virus surface antigen in a northern Nigerian population: An advocacy for aggressive vaccination
Rosanna Filosa, University of Naples, Italy
Title: Recent Advances in the Search for Novel Human 5-Lipoxygenase Inhibitors
Krishnan Chakravarthy, NanoAxis, LLC., USA
Title: Developing New Nanomedicine Technologies for the Treatment of Chronic Pain
Wasif Saif, Tufts Medical Center, USA
Title: Ovarian cancer treatment paradigm and potential utility of the novel IP agent Cantrixil (TRX-E-002-1)
Kiyonori Kai, Daiichi Sankyo Co., Ltd., Japan
Title: Neutrophil gelatinase-associated lipocal in urine as a non-clinical safety biomarker for acute kidney injury
Kirsi Ketola, Vancouver Prostate Centre, Canada
Title: Identification of novel inhibitors for the most aggressive and lethal prostate cancer subtype 1
N.K.Jain, Rajiv Gandhi Technical University, India
Title: Nanomaterials' Toxicity : How big is the issue?
Takashi Tsukamoto, Johns Hopkins University, USA
Maria Kontoyianni, Southern Illinois University Edwardsville, USA
X. Simon Wang, Howard University College of Pharmacy, USA
Title: Advanced machine learning to boost the accuracy of scoring function
Lei Xie, The City University of New York, USA
Title: Precision drug rescue and drug repurposing using structural systems pharmacology
Divya Singh, Central Drug Research Institute, India
Title: Possible roles of IL-12 cytokine family in management of post menopausal osteoporosis
Deepak Gupta, University of Delhi, India
Title: The facial-Re(CO)3 core Based Luminophores as Non-toxic Bio-imaging Agents
Shilpa Jain, University of Delhi, India
Title: Extended release of venlafaxine hydrochloride using Montmorillonite based excipients as a delivery vehicle
Taleb H. Al-Tel, University of Sharjah, UAE
Title: Privileged Substructures Diversity Oriented Synthesis: Rapid Access of Complex Compound Collections for Phynotypic Screening
Pemaiah Brindha, SASTRA University, India
Title: Studies on Nutraceutical, Safety and Toxicity Profiles of a Traditional Drug Source - Capparis spinosa L.
Simona Collina, University of Pavia, Italy
Title: Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising Sigma1 receptor agonist
Shadab Mohammad, King George’s Medical University, India
Title: Herbal Remedies for Mandibular Fracture Healing
Alaa Eldin Salem, United Arab Emirates University, UAE
Title: Selective molecular recognition of G-quadruplex DNA using small molecules: Insights on G-quadruplex stabilization and anticancer effects of some novel amino substituted thymoquinone derivatives
Tuan Anh Nguyen, University of South Australia, Australia
Title: Policy options for pharmaceutical pricing and purchasing: Issues for low and middle income countries
Abdul Rouf, University of Florida, USA
Title: Synthesis of Ofornine mimics from natural product l-Vasicine as anti-hypertensive agents
Bhaumik Pandya, Yumanity Therapeutics, USA
Title: Discovery of novel small molecules and targets for neuro-degenerative diseases through yeast based phenotypic screening